Independent US Healthcare Provider Directory & Public Medical Database Patient Guides

Brendan Sendrowski

Pharmacist - Oncology β€’ Seattle, WA

Active NPI 1528319399 Individual Practitioner Male Practitioner
Practice location in NPPES

825 Eastlake Ave E
Seattle, WA 981094405

Call 2062882017 Location details and other listings
Medical Disclaimer

This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.

Practice Location & Contact Primary Location

Practice Address

825 Eastlake Ave E

Seattle, WA 981094405

Telephone 2062882017
Organization at the Same NPPES Address or Phone
Fred Hutchinson Cancer Center Facility NPI 1164493847

Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.

30-day fills

40 standardized 30-day fills in 2013

CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.

What this does not show: 30-day fills

It is not a count of patients and not a measure of quality.

Part D drug cost

$39,294 in 2013

The total cost of these prescriptions in 2013, paid by Medicare drug plans, patients and other payers together.

What this does not show: Part D drug cost

A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.

Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2013.

NPI first issued

2012

The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.

What this does not show: NPI first issued

NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.

Source: CMS NPPES NPI Registry.

Medicare assignment not listed

CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.

Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.

Source: CMS Doctors and Clinicians; Medicare.gov, β€œDoes your provider accept Medicare as full payment?”

Guide: What Medicare assignment means

No telehealth indicator

CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.

Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.

Guide: How Medicare covers telehealth

Compared with the same specialty in Seattle and Washington

Billing and prescribing volume is not a quality rating.

Medicare Part D

Comparisons use 2024 data. The latest CMS data for Brendan Sendrowski are from 2013.

51 active clinicians are listed under Pharmacist - Oncology with a practice address in Seattle, WA (89 in Washington).

Addresses are self-reported to NPPES and may be out of date.

Telehealth indicator in Seattle

0% of these 51 clinicians have the CMS telehealth indicator.

0% of these 51 clinicians are listed by CMS as accepting Medicare assignment.

Sources: CMS Medicare Part D Prescribers (2013), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.

Text: T-MedInfo Β· Report an error.

Medicare Part D Prescribing Profile & Medications

Medicare Part D prescriptions filled, including refills, in 2013.

CMS Part D Β· Data Year 2013
Brand Name Generic Name Prescriptions Day Supply Total Cost Patients
Fentanyl Citrate Fentanyl Citrate 15 442 $38,336.87 β€”
Methadone Hcl Methadone Hcl 14 365 $463.20 β€”
Oxycodone Hcl Oxycodone Hcl 11 298 $494.30 β€”

Source: CMS Part D by Provider and Drug, 2013; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits

Specialties & License Numbers Reported to NPPES

Pharmacist - Oncology Primary Specialty

NUCC Taxonomy Code: 1835X0200X

License # reported to NPPES WA 1835X0200X

A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.

Check License Status with the State Board License numbers are self-reported to NPPES; T-MedInfo does not confirm them against state records. Current status: Washington State Department of Health Provider Lookup.
Look Up on State Board Site

Clinicians Sharing This Practice Address or Phone

Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.

1 listed
Dr. Helen Marshall , PharmD

Pharmacist - Oncology

NPI 1578743274

Doctor of Pharmacy (Pharm.D.)

Career & Practice History

NPI enumerated September 20, 2012.

No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.

No reviews have been published yet. Leave a review.

NPI Administrative Meta

NPI Number: 1528319399
Entity Type:
Individual Provider Physician, Nurse Practitioner, or Solo Healthcare Professional (Type 1 NPI)
Enumeration Date: September 20, 2012
Last Update: September 20, 2012
Sole Proprietor: No

Other Pharmacist - Oncology Specialists in Seattle

All Pharmacist - Oncology Specialists in Seattle

Mailing Address

825 Eastlake Ave E

Seattle, WA 981094405

Phone: 2062882017

About This Data NPPES fields (address, phone, specialty, license) are self-reported and may be outdated; Medicare fields follow the CMS dataset named in each section. Correct directly at NPPES.